Get the Stockscreener App
2.68
0.37%
-0.010
After Hours:
2.72
0.04
+1.49%
Nuvation Bio Inc Stock (NUVB) Forecast
The Nuvation Bio Inc (NUVB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.2141, representing a -92.01% decrease from the current price of $2.68. The highest analyst price target is $0.2529, and the lowest is $0.1754.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NUVB Price Target
Average 1.5398
(-42.55% Downside)
Is Nuvation Bio Inc (NUVB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.65 | Neutral |
| STOCH(9,6) | 35.29 | Neutral |
| STOCHRSI(14) | 30.29 | Neutral |
| MACD(12,26) | 0.00103 | Sell |
| ADX(14) | 14.42 | Neutral |
| William %R | -67.31 | Neutral |
| CCI(14) | -46.06 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.691
Sell
|
2.7032
Sell
|
| MA20 |
2.776
Sell
|
2.7152
Sell
|
| MA50 |
2.611
Buy
|
2.6879
Sell
|
| MA100 |
2.7029
Sell
|
2.7064
Sell
|
| MA200 |
2.8669
Sell
|
2.5599
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, NUVB could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 9 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on NUVB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 48.65 indicates that NUVB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 35.29 indicates that NUVB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.29 indicates that NUVB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.42 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -46.06 indicates that NUVB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NUVB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nuvation Bio Inc financial reports and earnings history, Nuvation Bio Inc (NUVB) stock could reach $5.3885 by 2030, $11.29 by 2040 and $25.52 by 2050. See the projected annual prices until 2050 of the Nuvation Bio Inc stock below:
- Nuvation Bio Inc (NUVB) is expected to reach an average price of $11.92 in 2035, with a high prediction of $12.03 and a low estimate of $12.05. This indicates an $344.81% rise from the last recorded price of $2.68.
- Nuvation Bio Inc (NUVB) stock is projected to chart a bullish course in 2040, with an average price target of $11.05, representing an $312.24% surge from its current level. The forecast ranges from a conservative $11.32 to a sky-high $11.29.
- Our analysts predict Nuvation Bio Inc (NUVB) to jump 576.04% by 2045, soaring from $18.24 to an average price of $18.12, potentially reaching $18.63. While $18.24 is the low estimate, the potential upside is significant.
- Nuvation Bio Inc (NUVB) stock is expected to climb by 2050, reaching an average of $25.43, a $848.76% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.52 and $25.52, respectively, highlighting the market's uncertainty.
Nuvation Bio Inc Stock (NUVB) Year by Year Forecast
Nuvation Bio Inc Stock (NUVB) Price Forecast for 2025
Nuvation Bio Inc Stock (NUVB) is expected to reach an average price of $1.5398 in 2025, with a high prediction of $3.0541 and a low estimate of $0.0255. This indicates an -42.55% fall from the last recorded price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.0646 | $0.1754 | $0.2529 | -97.59% |
| February, 2025 | $0.0155 | $0.0255 | $0.1445 | -99.42% |
| March, 2025 | $0.2645 | $0.028 | $0.2945 | -90.13% |
| April, 2025 | $0.5319 | $0.2295 | $0.5569 | -80.15% |
| May, 2025 | $0.5719 | $0.3469 | $0.6519 | -78.66% |
| June, 2025 | $1.3119 | $0.5894 | $1.4119 | -51.05% |
| July, 2025 | $1.8793 | $0.5643 | $3.0541 | -29.88% |
| August, 2025 | $1.8355 | $1.4268 | $2.2443 | -31.51% |
| September, 2025 | $1.4351 | $1.45 | $1.92 | -46.45% |
| October, 2025 | $1.3502 | $1.3601 | $1.3302 | -49.62% |
| November, 2025 | $1.3403 | $1.3752 | $1.3203 | -49.99% |
| December, 2025 | $1.0854 | $1.2142 | $1.2353 | -59.50% |
Nuvation Bio Inc Stock (NUVB) Price Forecast for 2026
The predicted value for Nuvation Bio Inc (NUVB) in 2026 is set at an average of $1.0298. Estimates vary from a peak of $1.9485 to a trough of $0.1112, indicating an -61.57% surge from the present price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.0755 | $1.1604 | $1.1054 | -59.87% |
| February, 2026 | $1.0855 | $0.9705 | $0.9505 | -59.49% |
| March, 2026 | $1.1456 | $1.0906 | $1.0506 | -57.25% |
| April, 2026 | $1.4607 | $1.3307 | $1.3757 | -45.49% |
| May, 2026 | $1.2208 | $1.4958 | $1.5458 | -54.45% |
| June, 2026 | $1.2709 | $1.2809 | $1.1758 | -52.58% |
| July, 2026 | $0.926 | $0.961 | $1.1559 | -65.45% |
| August, 2026 | $0.6561 | $0.9361 | $0.821 | -75.52% |
| September, 2026 | $0.5212 | $0.5612 | $0.6937 | -80.55% |
| October, 2026 | $0.0387 | $0.1112 | $0.2837 | -98.56% |
| November, 2026 | $0.7886 | $0.3863 | $1.9485 | -70.57% |
| December, 2026 | $0.06 | $0.12 | $1.1835 | -97.76% |
Nuvation Bio Inc Stock (NUVB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nuvation Bio Inc (NUVB) is $2.4134, with a high forecast of $2.9051 and a low forecast of $1.9217. This indicates an -9.95% decrease from the last price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.7901 | $2.9501 | $2.9051 | +4.11% |
| February, 2027 | $2.8603 | $2.8927 | $2.8403 | +6.73% |
| March, 2027 | $2.7079 | $2.8579 | $2.8153 | +1.04% |
| April, 2027 | $2.5281 | $2.6569 | $2.6055 | -5.67% |
| May, 2027 | $2.4882 | $2.5807 | $2.5331 | -7.16% |
| June, 2027 | $2.4858 | $2.3608 | $2.4258 | -7.24% |
| July, 2027 | $2.736 | $2.4509 | $2.446 | +2.09% |
| August, 2027 | $2.7761 | $2.661 | $2.6911 | +3.59% |
| September, 2027 | $2.5438 | $2.6238 | $2.8387 | -5.08% |
| October, 2027 | $2.4139 | $2.5239 | $2.4039 | -9.93% |
| November, 2027 | $2.144 | $2.179 | $2.3414 | -20.00% |
| December, 2027 | $1.9217 | $1.9217 | $2.0316 | -28.29% |
Nuvation Bio Inc Stock (NUVB) Price Forecast for 2028
In 2028, Nuvation Bio Inc (NUVB) is projected to reach an average price of $2.2386, with a high projection of $4.4526 and a low estimate of $0.0246. This indicates an -16.47% fall from the last price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.6718 | $1.7118 | $1.8667 | -37.62% |
| February, 2028 | $1.082 | $1.2319 | $1.3894 | -59.63% |
| March, 2028 | $0.6496 | $0.0246 | $0.9495 | -75.76% |
| April, 2028 | $1.51 | $0.1772 | $1.22 | -43.66% |
| May, 2028 | $4.3302 | $4.4252 | $4.4526 | +61.58% |
| June, 2028 | $4.3904 | $4.4199 | $4.3503 | +63.82% |
| July, 2028 | $4.1806 | $4.3306 | $4.3104 | +55.99% |
| August, 2028 | $4.0308 | $4.0995 | $4.0706 | +50.40% |
| September, 2028 | $3.771 | $3.901 | $3.9608 | +40.71% |
| October, 2028 | $3.8611 | $3.751 | $3.8011 | +44.07% |
| November, 2028 | $4.0213 | $3.8112 | $3.9013 | +50.05% |
| December, 2028 | $4.0615 | $3.9914 | $4.0065 | +51.55% |
Nuvation Bio Inc Stock (NUVB) Price Forecast for 2029
The 2029 price forecast for Nuvation Bio Inc Stock (NUVB) is $3.5651 on average, with a high prediction of $6.0076 and a low estimate of $1.1227. This represents an +33.03% increase from the previous price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.7017 | $3.8517 | $4.1316 | +38.12% |
| February, 2029 | $3.6319 | $3.6919 | $3.6618 | +35.52% |
| March, 2029 | $3.3521 | $3.397 | $3.4621 | +25.08% |
| April, 2029 | $3.1023 | $3.1023 | $3.1322 | +15.76% |
| May, 2029 | $2.7025 | $2.7725 | $3.0398 | +0.84% |
| June, 2029 | $2.1427 | $2.3525 | $2.2025 | -20.05% |
| July, 2029 | $1.7328 | $1.1227 | $1.1878 | -35.34% |
| August, 2029 | $6.1726 | $1.238 | $6.0076 | +130.32% |
| September, 2029 | $5.8628 | $5.9578 | $6.0002 | +118.76% |
| October, 2029 | $5.8455 | $5.9354 | $5.8604 | +118.12% |
| November, 2029 | $5.6258 | $5.6658 | $5.7607 | +109.92% |
| December, 2029 | $5.466 | $5.5422 | $5.4733 | +103.95% |
Nuvation Bio Inc Stock (NUVB) Price Forecast for 2030
Nuvation Bio Inc Stock (NUVB) is expected to reach an average price of $4.8955 in 2030, with a high forecast of $7.5701 and a low forecast of $2.2209. This signifies an +82.67% surge from the last price of $2.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.1487 | $5.2987 | $5.3885 | +92.12% |
| February, 2030 | $5.199 | $5.1413 | $5.1764 | +93.99% |
| March, 2030 | $5.3592 | $5.1715 | $5.2392 | +99.97% |
| April, 2030 | $5.3694 | $5.3217 | $5.3218 | +100.35% |
| May, 2030 | $4.9722 | $5.1222 | $5.4245 | +85.53% |
| June, 2030 | $4.8724 | $4.9324 | $4.9247 | +81.81% |
| July, 2030 | $4.4352 | $4.5452 | $4.695 | +65.49% |
| August, 2030 | $4.2854 | $4.2828 | $4.3277 | +59.90% |
| September, 2030 | $3.8456 | $3.9156 | $4.0579 | +43.49% |
| October, 2030 | $1.8884 | $3.4732 | $3.3381 | -29.54% |
| November, 2030 | $2.6986 | $2.2209 | $2.5886 | +0.69% |
| December, 2030 | $7.7351 | $2.2987 | $7.5701 | +188.62% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):